S-(4-nitrobenzyl)glutathione

Summary

S-(4-Nitrobenzyl)glutathione is a synthetic glutathione analogue in which the cysteine thiol is substituted with a 4-nitrobenzyl thioether. It is a potent and well-characterized competitive inhibitor of glyoxalase I, used extensively as a biochemical tool in research on glyoxalase pathway inhibition for antiparasitic (e.g., Trypanosoma, Plasmodium) and anticancer applications. It has no approved clinical use and remains a research compound.

Mechanism of Action

Acts as a competitive inhibitor of glyoxalase I (Lactoylglutathione lyase, EC 4.4.1.5), competing with the hemithioacetal substrate formed from methylglyoxal and glutathione. By blocking glyoxalase I, it impairs the detoxification of methylglyoxal, leading to accumulation of cytotoxic methylglyoxal in cells, particularly exploited in antiparasitic and anticancer research contexts.

Routes of Administration

Goals & Uses

• Glyoxalase I inhibitionEnzyme Inhibition / Biochemical ToolHigh
• Anticancer researchOncologyLow
• Methylglyoxal pathway modulationMetabolic ResearchHigh
• Antiparasitic research (Trypanosomiasis, Malaria)AntiparasiticModerate

Contraindications

• Human clinical useRegulatoryHigh

Adverse Effects

• General glutathione pathway disruptionOxidative StressUnknown
• Cytotoxicity (methylglyoxal accumulation)Cellular ToxicityUnknown

Drug Interactions

• Glutathione and GSH-related agentsLow

Population Constraints

• All human populationsGeneralAbsolute

Regulatory Status

• European UnionUnapprovedResearch use only; not evaluated by EMA.
• United StatesUnapprovedResearch use only; no IND or NDA on record for this compound.
• United KingdomUnapprovedResearch use only; not evaluated by MHRA.

Not approved by any regulatory agency (FDA, EMA, MHRA) for human use. Used exclusively as a biochemical research tool and in preclinical studies.

Evidence & Sources

No sources recorded yet.